Avalo Therapeutics, Inc.

Industry

  • Biotechnology
    • Large Molecule
      • Antibodies
  • Pharmaceuticals
    • Specialty Pharmaceuticals
    • Vaccines

Other Names/Subsidiaries

  • Aevi Genomic Medicine
  • Cerecor
  • Ichorion Therapeutics
  • TRx Pharmaceuticals
  • Trx Pharmaceuticals
  • Zylera Phamaceuticals.
See more in Biomedtracker

Latest on Avalo Therapeutics, Inc.

Scrip

Deal Watch: Gilead Acquires Xilio’s IL-12 Activating Candidate

 
• By Joseph Haas and Alaric DeArment

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Gilead Gets Xilio’s Phase I Cancer Drug

Scrip

Neumora Reveals Mid-Stage Data For Fully Funded, Phase III-Ready Depression Drug

 
• By Mandy Jackson

Privately held Neumora Therapeutics, Inc. has one well-funded rival in the late-stage development of a kappa opioid receptor (KOR) antagonist for the treatment of major depressive disorder (MDD), bu

Scrip

Deal Watch: BMS Backs Out Of UniQure Gene Therapy Collaboration

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. BMS Exits 2015 Gene Therapy Partnership

Scrip

Deal Watch: Gemini Goes Through Second Re-Invention Via Reverse Merger With Disc Medicine

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Disc Goes Public As Gemini Downshifts F